Clinical AI & Digital Health Commercialization
From market entry and fundraising narrative to scaling established commercial teams — Corvelo Advisory works with clinical AI and digital health companies at every stage of growth.
"The gap between a great clinical AI product and US commercial traction is almost never technical. It's structural."
Who We Serve
Corvelo Advisory works with clinical AI and digital health companies across imaging, cardiology, neurology, surgical, and workflow AI — at every stage of the commercial journey. Whether you're building your first US commercial infrastructure, preparing for a fundraise, or leading a product marketing org at an established company, the challenge is the same: translating clinical credibility into commercial momentum.
Diagnostic imaging, FFR analysis, arrhythmia detection, cardiac wearables, and catheter-based device companies navigating complex clinical and commercial pathways.
AI-native PACS viewers, workflow triage platforms, oncology biomarkers, and foundation models for CT, MRI, and X-ray across clinical and research settings.
Robotic surgery platforms, endovascular device companies, navigation systems, and AI-assisted procedure tools selling into complex hospital systems.
Ambient documentation, clinical decision support, neurostimulation, and enterprise AI platforms embedded in physician and care team workflows.
European and APAC companies with proven clinical technology who need a structured path into US health systems — without guessing how the market actually works.
Founders preparing for fundraising or commercial launch who need go-to-market strategy, ICP definition, pricing architecture, and a fundraising commercial narrative built from scratch.
Established commercial teams at larger digital health and medtech companies that need senior advisory on product marketing strategy, positioning, market expansion, and commercial operations.
Services
Focused engagements with defined deliverables — for companies at every stage, from pre-commercial through established growth.
Target customer profile, ICP definition, channel strategy, and a ranked list of first-mover US institutions — built from real market research for companies entering the US market.
Early StageUS pricing framework, pre-FDA-clearance commercial playbook, pilot-to-contract conversion strategy, and go-to-market sequencing for clinical AI companies at any stage.
Early & Growth StageTranslating clinical credibility into investor language — TAM/SAM/SOM, pipeline metrics, revenue model, and a customer thesis that VCs and institutional investors can fund with confidence.
Series A / BSenior advisory for established product marketing and commercial teams at growth-stage digital health and medtech companies — positioning, messaging, competitive strategy, and market expansion.
Growth StageMarket sizing, competitive landscape, and go-to-market assessment for VCs and PE firms evaluating clinical AI and digital health investments — scoped to commercial and market questions with domain expertise.
VC / PE AdvisoryAbout
Scott Hao founded Corvelo Advisory after a career spanning the full spectrum of healthcare commercialization — from enterprise medtech at Abbott and Siemens, to building commercial functions from scratch at early-stage clinical AI startups, to senior product management roles at established AI imaging companies.
Most recently Senior Product Manager for Cardiology AI at RapidAI, Scott has direct experience taking AI-driven products into US health systems across imaging, cardiology, and neurology — navigating hospital procurement, building clinical champion relationships, and converting pilots into contracts.
"The gap between a great clinical AI product and commercial traction is almost never technical. It's structural — and it's exactly the gap we exist to close."
Get in Touch
Whether you're building your first US commercial infrastructure, preparing for a fundraise, or advising a product marketing org at an established company — let's talk about what you're working on.
Connect on LinkedIn